Sobi to advance Gamifant in interferon-gamma-driven sepsis based on EMBRACE topline data: Stockholm Friday, January 9, 2026, 11:00 Hrs [IST] Sobi, a global biopharma company, anno ...

Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for ...

Sobi (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant (emapalumab) for interferon-gamma (IFN?)-driven ...

Scientists are testing the ancient herb borage to see which healing claims hold up and where modern evidence still falls ...

New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung ...

The Phase 2a trial enrolled 35 IPF patients randomized in a 2:1 ratio to receive either GRI-0621 or placebo once daily for 12 weeks. A sub-study examined immune cells in bronchoalveolar lavage fluid ...

Walnuts also have potent connections to brain health and aging. In fact, some studies suggest that walnuts may improve certain markers of brain function and help reduce the oxidative stress that ...

Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...

Bitcoin compression below $100K is temporary as dealer hedging expires by February. Mathematical analysis reveals imminent ...

Govee is showing us that smart lights can do more than just turn on/off or switch colors. They can adapt to your mood, ...

BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...

At CES 2026, Govee is unveiling a new generation of core lighting technologies, alongside a preview of three flagship products that push ...